Cancer as a Metabolic & Immune Disease: Diet, Drugs, and Science Explained (2026 Public Guide)

By Editorial Team -

Introduction: A Broader View of Cancer Biology

Traditional oncology often focuses on genetic mutations and targeted therapies. While mutations are critical, emerging research shows that cancer is also a disease of metabolic dysfunction and immune dysregulation. Understanding these systemic drivers can inform investigational therapies, repurposed drugs, and adjunctive strategies. This perspective — supported by researchers like Dr. Thomas Seyfried and others — sees cancer as a disorder rooted in metabolic dysfunction and immune evasion. (One Day MD)

Immunometabolism is an emerging interdisciplinary field that explores the intricate relationship between metabolic processes and immune system activity, bridging the disciplines of immunology and metabolism. (1)

At OneDayMD, we analyze cancer using a mechanistic, evidence-based, and clinically cautious approach, highlighting metabolic and immune pathways that influence tumor growth, progression, and response to therapy.


Keywords: cancer metabolism and immunity, metabolic immune disease of cancer, metabolic therapy explained

Why Metabolic and Immune Perspectives Matter

Cancer cells frequently rewire their energy systems:

  • Dependence on glucose and amino acids: Many tumors heavily rely on glucose and glutamine for energy and growth. (One Day MD)

  • Mitochondrial dysfunction: According to Seyfried’s metabolic theory, damaged mitochondria push cells toward fermentation (like glycolysis) and away from healthy oxidative energy production — a hallmark of cancer cells. (One Day MD)

  • Energy flexibility: Tumors may adapt to use alternative energy sources when glucose is limited, which complicates simple dietary approaches. (OUP Academic)

  • Immune Evasion: Tumors exploit immune checkpoints, suppress cytotoxic T cells, and promote regulatory T cells to escape immune detection.

This metabolic shift can support rapid growth and resistance to therapy and is a key target in metabolic therapy research.

Keywords: cancer energy metabolism, glucose glutamine cancer, mitochondrial dysfunction

Insulin Resistance May Be Driving 12 Types of Cancer - Nature (2026)

Insulin resistance has been linked to a 25% higher risk of 12 different types of cancer, according to new findings published February 16, 2026 in Nature Communications.

Researchers from the University of Tokyo and Taichung Veterans General Hospital in Taiwan developed an artificial intelligence (AI) tool to predict insulin resistance.

The AI tool identified patients with insulin resistance and flagged higher risks of developing diabetes, heart disease, and cancer.

The association between insulin resistance and cancer incidence was strongest for uterine cancer, with a 134% increased risk.

How the Immune System Interacts with Metabolism

Cancer also manipulates the immune system to its advantage:

  • Immune evasion: Tumors express proteins that inactivate immune responses (like PD‑1/PD‑L1).

  • Inflammation & suppression: Tumor environments often contain immune cells that suppress anti‑tumor activity.

  • Metabolic competition: Cancer cells can monopolize nutrients, weakening immune cell function.

These immune effects are tightly linked to metabolism — for example, acidic metabolites from tumor cells can dampen T‑cell activity — making the immune system a crucial part of the metabolic cancer landscape. (arXiv)

Keywords: immunometabolism cancer, cancer immune suppression, nutrient competition immune cells.

Key Metabolic Pathways in Cancer

The Warburg Effect

Cancer cells preferentially use glycolysis for energy even under oxygen-rich conditions. This supports biosynthesis, rapid proliferation, and resistance to apoptosis. Investigational therapies target glycolytic enzymes, glucose transporters, or mitochondrial metabolism.

Insulin and IGF-1 Signaling

Elevated insulin and IGF-1 can promote tumor growth via the PI3K/AKT/mTOR pathway. Drugs like metformin are under investigation to modulate these pathways in oncology.

mTOR and AMPK Regulation

The mTOR pathway controls protein synthesis, cell growth, and metabolism. AMPK activation can counteract tumor proliferation. Understanding these pathways allows repurposed or off-label therapies to be considered in adjunctive roles.

Thomas Seyfried’s Metabolic Theory of Cancer

Cancer as a Primarily Metabolic Disorder

Dr. Thomas N. Seyfried, a leading metabolic cancer researcher, proposes that:

  • Cancer originates from metabolic dysfunction, especially mitochondrial damage, not primarily from genetic mutations. (One Day MD)

  • Cancer cells generate energy mainly by fermentation of glucose and glutamine, not by oxidative respiration. (Metabolic Therapy)

  • If both primary fuels (glucose & glutamine) are restricted, cancer cells struggle to survive, while healthy cells adapt more easily. (Metabolic Therapy)

This view challenges conventional genetic‑centric theories and reframes cancer as a metabolic and energy dysregulation disease.

Keywords: metabolic theory of cancer, Seyfried cancer metabolism, Warburg effect expanded

Press‑Pulse Metabolic Therapy Concept

Seyfried and collaborators advocate an integrative press‑pulse strategy that combines:

  1. Dietary changes: Especially ketogenic or low‑carb nutrition to lower glucose availability and encourage ketone production. (One Day MD)

  2. Pharmaceutical targeting: To reduce glutamine availability and inhibit cancer metabolism with safe drugs, as diet alone can’t fully limit glutamine. (Metabolic Therapy)

  3. Lifestyle and stress management: Supporting overall metabolic resilience. (One Day MD)

The idea is to “starve” cancer cells of their preferred fuels while supporting normal cells and immune health. This approach remains experimental and is not a replacement for standard oncology treatments. (One Day MD)

Keywords: press pulse therapy, ketogenic metabolic therapy, cancer fuel restriction.


Immune Dysregulation in Cancer

Checkpoint Pathways

Tumors exploit PD-1, PD-L1, and CTLA-4 to suppress immune responses. Checkpoint inhibitors have revolutionized oncology, but metabolic and microenvironmental factors influence response rates.

Inflammation and Cytokine Networks

Chronic inflammation supports tumor initiation and progression. IL-6, TNF-α, and TGF-β pathways are often dysregulated, providing investigational targets for immune modulation.

Tumor Microenvironment and Fibrosis

Dense extracellular matrix, hypoxia, and stromal cell interactions create barriers to immune infiltration and drug delivery. Therapies targeting the microenvironment are an active area of research.

Dietary Metabolic Strategies

Ketogenic & Low‑Carb Diets

  • Goal: Lower circulating glucose, elevate ketone bodies (which most tumors can’t use for fuel). (One Day MD)

  • How it’s thought to help: Reduced glucose may stress cancer cells that rely heavily on glycolysis.

  • Limitations: Evidence from randomized trials is limited, and long‑term strict diets may have metabolic and nutritional downsides — including muscle loss and hormone changes — when not medically supervised. (One Day MD)

Keywords: ketogenic therapy cancer, keto diet cancer evidence

Calorie Restriction & Fasting

Intermittent fasting, time‑restricted eating, or short water‑only fasts can further lower glucose and insulin. Some early research suggests improved response to treatment, but large clinical trials are lacking. (One Day MD)

Keywords: fasting cancer metabolism, intermittent fasting cancer research


Repurposed & Off-Label Drugs Targeting Metabolic & Immune Pathways

Researchers are exploring medications with metabolic or immuno-modulatory effects:

  • Metformin: May affect energy pathways and insulin signaling.

  • Glutamine inhibitors: Aimed at reducing an alternative fuel cancer cells use. (Metabolic Therapy)

  • Immune‑modulating agents: Support immune response and may indirectly influence metabolism.

  • Low-Dose Naltrexone (LDN) – Immune checkpoint modulation

  • Fenbendazole & Mebendazole – Microtubule disruption, apoptosis induction

  • Statins – Immune modulation, anti-inflammatory effects

  • Disulfiram – Aldehyde dehydrogenase inhibition, tumor stem cell targeting

These approaches are experimental, often off‑label, and must be evaluated in clinical trials with medical supervision.

Keywords: metabolic cancer drugs, glutamine inhibition cancer, drug repurposing oncology.

Potential Benefits and Current Evidence

Possible benefits include:

  • Making cancer cells more susceptible to therapies

  • Improving metabolic health

  • Supporting immune function

Limitations and realities:

  • Large, definitive clinical trials are still limited. (One Day MD)

  • Metabolic approaches may not be effective for all cancer types.

  • Safety and nutritional balance are critical and require professional guidance.

Keywords: benefits of metabolic therapy, cancer research evidence

Practical Guidance for Patients & Caregivers

  1. Always consult your oncologist before making major dietary, drug, or lifestyle adjustments.

  2. Consider clinical trials that scientifically evaluate metabolic or immune‑metabolic interventions.

  3. Support holistic health with balanced nutrition, exercise, stress management, and sleep.

  4. Understand that metabolic strategies are supportive, not stand‑alone cures.

Keywords: cancer patient metabolic support, integrative cancer care.

Integrative Strategies and Adjunctive Approaches

Beyond pharmacology, systemic interventions can influence metabolic and immune drivers:

  • Dietary modulation (ketogenic or low-insulinogenic diets)
  • Exercise and metabolic conditioning
  • Sleep and circadian alignment
  • Supplemental immune support (vitamin D, omega-3s, curcumin) under clinical guidance

These approaches may enhance standard-of-care therapy but are always context-dependent and investigational.

Conclusion

Modern research increasingly recognizes that cancer is not only about genetics — it’s deeply connected to metabolic dysfunction and immune interactions. Scientists like Thomas Seyfried have expanded this view to propose novel metabolic strategies that target cancer’s fuel use, providing a conceptual complement to standard treatments. (One Day MD)

While promising, these approaches are experimental and best discussed with qualified medical teams. Scientific evidence continues to evolve, and future research may clarify how to optimize metabolic and immune‑focused therapies within integrated cancer care.

At OneDayMD, we aim to provide a structured, evidence-based perspective that empowers patients, caregivers, and clinicians to understand the full landscape of cancer biology—beyond what guidelines alone convey.

References

  1. Chavakis T. Immunometabolism: Where Immunology and Metabolism Meet. J Innate Immun 2022; 14: 1-3. 20211214. DOI: 10.1159/000521305.
  2. Immunometabolism in lung cancer - The link between metabolism and immune response (ScienceDirect 2026)
  3. Immunometabolism in cancer: basic mechanisms and new targeting strategy (Nature 2024)
  4. The immunometabolic ecosystem in cancer (Nature 2023)

Related Guides

Disclaimer: This content is educational. It is not medical advice. All investigational strategies should be discussed with a qualified clinician.

Comments

Post a Comment

Labels

Show more

Archive

Show more

Popular posts from this blog

Fenbendazole, Ivermectin and Mebendazole Cancer Success Stories: 590 Case Reports Compilation (March 2026 Edition)

By Editorial Team -
Image
Table of Contents: Editor's Preface Introduction Fenbendazole Case Series Compilation (alphabetical) Breast Cancer Success Stories  (77 cases) Brain Cancer (including Glioblastoma) (119 cases) Bile Duct Cancer (Cholangiocarcinoma)  (4 cases) Bladder Cancer Success Stories  (including kidney cancer) (29 cases) Cervical Cancer  (6 cases) Colorectal Cancer  (including Appendix cancer) (51 cases) Esophageal and Stomach cancer (21 cases) Endometrial Cancer (9 cases) Gastric (Stomach) cancer (see  Esophageal and Stomach Cancer ) (21 cases) Head and Neck Cancer (15 cases) Kidney Cancer Case Series  (including urinary (urothelial) bladder cancer) (27 cases) Liver Cancer (HepatoCellular Cancer)  (3 cases) Lung Cancer (40 cases) Leukemia (9 cases) Lymphoma (23 cases) Melanoma (refer to Skin Cancer ) ...
Read more

Ivermectin and Fenbendazole: Treating Turbo Cancer - Dr William Makis

By Editorial Team -
Image
Ivermectin Resources I have seen tremendous demand for some sort of initial guidance “WHERE TO START” with High Dose Ivermectin for CANCER. Editor's Note: Dr Makis proposes four distinct cancer protocols for using Ivermectin in cancer treatment, specifically for patients who have developed turbo cancer or aggressive cancers. These protocols, referred to as the “Dr. Makis Ivermectin Cancer Protocols,” are categorized based on dosage and the severity of the cancer. Updated version I have an article and a video that go into depth: June 10, 2024 - "15 minutes with Dr.Makis" - Episode 018: High Dose Ivermectin and Cancer .  2025 - 2026 studies on ivermectin for cancer Clinical Yuan Yuan et al (Cedars-Sinai Medical Center) - A phase I/II study evaluating the safety and efficacy of ivermectin in combination with balstilimab in patients with metastatic triple negative breast cancer (ASCO 2025) Yuwen et al -  A Review of Ivermectin Use in Cancer Patients: Is it Time to Repurpose t...
Read more

Fenbendazole Joe Tippens Protocol: A Step-by-Step Guide (2026)

By Editorial Team -
Image
If you have been diagnosed with cancer, or have a loved one that is suffering from cancer, chances are you have heard about the Joe Tippens Cancer Protocol. The Fenbendazole Cancer Protocol has been gaining rapid interest over the past years following some fenbendazole advanced cancer success stories . We have seen tremendous demand for some sort of guide on how to use fenbendazole for cancer as there is also tremendous confusion both from the healthcare and non-healthcare communities. Joe Tippens founded the protocol (1) after he was told a story about a scientist at Merck Animal Health that had been performing cancer research on mice. The research included injecting different types of cancers into different mice body parts. The scientists discovered, through trial and error, a product in their canine product line, fenbendazole, that was batting 1.000 in killing these different cancers in the mice. The scientist was later diagnosed with ...
Read more

Dr William Makis Ivermectin Protocol 2026 – Complete Guide + Patient Outcomes

By Editorial Team -
Image
Dr. William Makis MD (McGill Medicine, 110+ peer-reviewed publications) runs the world's largest high-dose ivermectin cancer clientele in 2025 – he has guided thousands of patients globally with remarkable results in turbo cancers and conventional failures. This continuously updated 2026 guide compiles Dr. Makis's latest protocols (from his Substack, X posts through 2026, and direct patient correspondence). We cross-reference his exact dosages, schedules, combinations, safety data, sourcing, and real patient outcomes (anonymized but verifiable on his channels). Important Disclaimer: This content is for educational purposes only and does not constitute medical advice. Ivermectin is used off-label for cancer treatment. Always consult with a knowledgeable physician whom you trust to manage your health. Individual results may vary. Do not self-medicate with ivermectin without proper bloodwork and medical monitoring, as misuse can lead to serious side effects and drug interactions. ...
Read more

Best Ivermectin Dosage for Humans with Cancer or Different Cancer Types (2026)

By Editorial Team -
Image
Introduction This article discusses dosage considerations and key factors regarding the use of ivermectin in cancer treatment. Commonly available information about ivermectin dosages is often inaccurate when applied to potential cancer-related uses.  Many sources cite standard dosages recommended by Merck for treating parasitic infections, rather than dosages studied specifically in the context of cancer research. The anti-parasitic dosage is not as effective for people looking for a dosage against cancer. Dosage will need to be adjusted according to the  current weight, the type of Cancer, the stage and grade of the Cancer and the health of the liver. Ivermectin dosage should also be based on ivermectin cancer studies. Multiple factors are considered including studies including ivermectin for cancer, anecdotal studies and case series, the aggressiveness of the cancer type and the cancer stage. It also takes into account the types of medications the person uses. For example, i...
Read more

Ivermectin, Fenbendazole and Mebendazole Protocol in Cancer: Peer-Reviewed Protocol in Cancer

By Editorial Team -
Image
We are pleased to announce that the first-of-its-kind protocol utilizing Ivermectin, Mebendazole, and Fenbendazole for cancer treatment has been peer-reviewed and officially published on September 19, 2024. Spearheaded by leading researchers like Dr. Ilyes Baghli, Dr. Pierrick Martinez, and the FLCCC’s Dr. Paul Marik, this groundbreaking protocol harnesses the untapped power of Ivermectin, Mebendazole, and Fenbendazole, known for their effectiveness against parasites. Now, these drugs are showing potential to battle cancer, marking the dawn of a new treatment evolution. This trio of repurposed drugs has been shown to disrupt the growth of cancer cells, particularly by targeting microtubules, the essential structures that allow cancer to multiply uncontrollably. What makes this protocol even more potent is the synergistic effect when these drugs are used together, creating a powerful new affordable weapon against cancer. Journal of Orthomolecular Medicine 2024 Targeting the Mitochondri...
Read more

Ivermectin Dosage Guide for Humans (2025)

By Editorial Team -
Image
In this Article: Overview of Ivermectin Dosage | Ivermectin Dosage for Adults | Ivermectin Dosage for Children | Ivermectin dosage restrictions | How to take ivermectin | Ivermectin dosage FAQs The prescribed dosage for ivermectin oral tablets depends on the type of parasitic infection you have and your body weight. Ivermectin is typically taken as a single dose. Repeat doses may be needed in some cases. Specifically, ivermectin oral tablet is approved by the Food and Drug Administration (FDA) to treat the following conditions in adults and certain children: a parasitic infection in the intestinal tract called strongyloidiasis a parasitic infection of the eyes and skin called onchocerciasis  (River Blindness) Ivermectin oral tablet is a generic medication and belongs to a drug class called antiparasitic medications. It is also available in a brand-name version called Stromectol. This article describes the dosages of ivermectin oral tablets, as well as the medication’s streng...
Read more

DMSO 101: Benefits, Uses, Dosage and Side Effects (2026)

By Editorial Team -
Image
In 2022, Erica Eyres, a vigorous fifty-six-year-old aerobics instructor who had struggled to breathe, was given “absolutely devastating” news: She might need a lung transplant. She had never smoked, ran cross-country track in high school, and was a personal trainer for years, but, by 2024, a transplant assessment was arranged. (1) “I decided that I will make that decision,” she said, “only if it’s the last resort, and I’m on my deathbed.” A few months before her consultation, however, Eyres, then fifty-eight, made an appointment with a new primary care doctor for routine prescription refills. She was about to be introduced, literally and figuratively, to a new kind of medicine. It would change everything. DMSO Online Buying Guide (Paid Link) Buy on Amazon Disclosure: OneDayMD.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program that enables sites to earn advertising fees by advertising and linking to Amazon.com, but this is at NO extra co...
Read more

Best Fenbendazole Dosage for Humans: Safety, Side Effects and Efficacy Examined (2026)

By Editorial Team -
Image
Fenbendazole is a broad spectrum anti-parasitic used against gastrointestinal parasites including: giardia, roundworms, hookworms, whipworms, the tapeworm genus Taenia (but not effective against Dipylidium caninum, a common dog tapeworm), pinworms, aelurostrongylus, paragonimiasis, strongyles, and strongyloides that can be administered to sheep, cattle, horses, fish, dogs, cats, rabbits, most reptiles, freshwater shrimp tanks as planaria and hydra treatments, as well as seals. (2) Fenbendazole, has garnered ⁤attention​ for its potential use ​in‍ humans.‍ The Fenbendazole Cancer Protocol gained rapid interest over the past years following some fenbendazole advanced cancer success stories  (more than 500 case reports). Joe Tippens founded the protocol  after he was told a story about a scientist at Merck Animal Health that had been performing cancer research on mice. The research included injecting different types of cancers into different m...
Read more

Ivermectin Tested against 28 types of Cancer: Most Sensitive vs Least Sensitive

By Editorial Team -
Image
A research group from Mexico investigated Ivermectin in Cancer. This is the first study that has tested as many as 28 Cancer types with Ivermectin.  Paper: 2020 (Juarez et al) - Antitumor effects of ivermectin at clinically feasible concentrations support its clinical development as a repositioned cancer drug.  Ivermectin was tested at 2mg/kg/day which translates to roughly 5uM in vitro concentration. The most sensitive cancer cell lines were: 1. Ovarian 2. Breast 3. Glioblastoma 4. Lung Cancer 5. Colon Cancer 6. Uterine SCC 7. hepatocellular 8. breast TNBC 9. Pancreatic 10. Endometrial. Least sensitive were: 1. osteosarcoma 2. gastric 3. melanoma  Although lymphoma and leukemia cell lines appear to be more resistant to Ivermectin, Ivermectin has a significant impact on those cells' ability to form colonies. So yes, Ivermectin is useful against BOTH lymphomas and leukemias.  Ivermectin also goes after CANCER STEM CELLS, which tend to be resistant to chemotherapy: ...
Read more